Publication | Closed Access
How “suspicious” is that nodule? Review of “suspicious” Afirma gene expression classifier in high risk thyroid nodules
17
Citations
11
References
2017
Year
The rate of malignancy in nodules suspicious by Afirma was 18.3% (11/60). The rate of malignancy in nodules suspicious for neoplasm (SN) on cytology interpretation was 31.2% (5/16). False positive rate of Afirma was 56% (32/57). We conclude that cytology interpretation has a higher rate of predicting malignancy, in nodules interpreted as SN, when compared with the Afirma test, by almost twofold Diagn. Cytopathol. 2017;45:308-311. © 2016 Wiley Periodicals, Inc.
| Year | Citations | |
|---|---|---|
Page 1
Page 1